Symptom Management for Peripheral Neuropathy in HIV
This is a 15-week, randomized, double blind, controlled NIH-funded clinical trial investigating the efficacy of acupuncture/moxibustion in reducing pain/discomfort associated with HIV related peripheral neuropathy.
Adults, age 18 years or older, HIV+ or AIDS diagnosed, with a history of distal sensory peripheral neuropathy of the lower extremities for the past three months or greater.
- HIV+ or AIDS
- Experiencing pain/discomfort, numbness, aching, burning or “pin and needles” sensation in the lower legs and/or feet for the past three months or greater.
- Primary care provider verification: HIV status, diagnosis/evidence of distal sensory peripheral neuropathy, and subject clinical suitability for the study.
- Any acute condition requiring medical care (e.g. opportunistic infection).
- Conditions that may mimic HIV distal sensory peripheral neuropathy symptoms: i.e. diabetes, coagulopathies, B12 deficiency, etc.
Subjects will attend a total of 16 session over a period of 15 weeks. All sessions will take place in the acupuncture suite at New York University College of Nursing.
Patients will attend one intake session, twelve (12) acupuncture sessions (twice weekly for 6 weeks, and three (3) follow up sessions.
Measurements of quality of life and level of functioning will be taken. All subjects will complete daily symptom and medication diaries and questionnaires for the duration of the study.
BENEFITS AND COMPENSATION:
Participants will receive $10 per session at the end of the intake session and the first 12 treatment sessions, $20 for the first follow up session, $30 for the second follow up session and $40 for the final follow-up session. The total compensation for participation is up to $220. Participants will also receive a roundtrip MetroCard at the end of each session.
Joyce K. Anastasi, PhD, DrNP, FAAN, LAc
Director, Special Studies in Symptom Management